Liste de favoris
La liste de favoris est vide.
Le panier est vide.
Envoi gratuit possible
Envoi gratuit possible
Veuillez patienter - l'impression de la page est en cours de préparation.
La boîte de dialogue d'impression s'ouvre dès que la page a été entièrement chargée.
Si l'aperçu avant impression est incomplet, veuillez le fermer et sélectionner "Imprimer à nouveau".

Acute Myeloid Leukemia in Children

Standard of Care and Future Perspectives
Livre numériquePDFLivres électroniques
Classement des ventes 4dansMedicine (eBook)
CHF165.50

Description

This book provides up-to-date information on key topics and issues in Pediatric Acute Myeloid Leukemia (AML), including the epidemiology, biology, diagnosis and treatment of particular forms of the disease, supportive care, and survivorship. The entire spectrum of clinical management on pediatric AML is covered with the aim of equipping readers with the latest knowledge relevant to clinical practice and research, based on enormous efforts made by cooperative clinical trial groups and consortia worldwide. Each chapter is written by internationally renowned authorities who have been selected for their expertise in the subjects discussed. This book will serve pediatric hematologists/oncologists, fellows, and residents both as a comprehensive source of information and as a quick reference. The book will also be of interest to pediatricians and general practitioners.

Détails

Autres ISBN/GTIN9783031633669
Type de produitLivre numérique
ReliureLivres électroniques
FormatPDF
Indications sur le formatfiligrane
Date de parution20.08.2024
Edition24001 A. 2024
SériePediatric Oncology
Pages342 pages
LangueAnglais
Taille fichier25955 Kbytes
IllustrationsVIII, 342 p. 41 illus., 39 illus. in color.
Groupe de produitsLivre numérique anglais
CatégorieMedicine (eBook)
Plus de détails

Série

Evaluations

Auteur

Dr. Daisuke Tomizawa is a pediatric hematologist/oncologist and Head of the Division of Leukemia and Lymphoma at the Children's Cancer Center, National Center for Child Health and Development in Tokyo, Japan. He served as Vice Chair of the Japan Children's Cancer Group (JCCG) acute myeloid leukemia (AML) disease committee from 2010-2019 and Chair from 2019-2023, which is responsible for the design and conduct of clinical trials and linked translational research studies that enroll approximately 80% of Japanese children and adolescents with this disease. He is also involved in various international research projects in collaboration with North American, Western European, and Asian investigators in this field.

Dr. Edward Anders Kolb is a pediatric hematologist/oncologist, and most recently served as Chief of the Division of Hematology and Oncology of Nemours Children´s Health, Wilmington, Delaware, and Professor of Pediatrics, Sidney Kimmel Medical College at Thomas Jefferson University. Dr. Kolb also served as Chair of the Children´s Oncology Group (COG) Myeloid Disease Committee from 2013-2023, which is the largest pediatric AML research consortium in the world. He is a strong advocate for international collaboration and leads the development of several international clinical trials. Since 2023, Dr. Kolb was appointed as President and Chief Executive Officer, The Leukemia & Lymphoma Society (LLS) in its mission to cure blood cancers and improve the quality of life for patients and their families.

Prof. Dr. Dirk Reinhardt is a pediatric hematologist/oncologist and Head of Pediatrics III, Pediatric Hematology, Oncology and Stem Cell Therapy at the University Children's Hospital Essen, Germany. He is chairman of the AML-BFM study group, which conducts clinical trials as well as basic and translational research on pediatric AML. As Managing Director of the German Society for Pediatric Oncology and Hematology (GPOH gGmbH) and Director of the EuPAL Foundation, he promotes international projects in drug and therapy development for the treatment of cancer and leukemia in children.

 

Plus de produits de Tomizawa, Daisuke

Editeur

Recommandations

Recherches récentes